| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 6e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.0003 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.79 | 0.0008 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.003 |